UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023349
Receipt number R000026905
Scientific Title A multicenter prospective study for the utility of a target sample check illuminator (TSCI), concerning the detection of target specimens in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) samples for pancreatic masses and lymph node tumors.
Date of disclosure of the study information 2016/07/27
Last modified on 2022/08/01 17:14:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter prospective study for the utility of a target sample check illuminator (TSCI), concerning the detection of target specimens in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) samples for pancreatic masses and lymph node tumors.

Acronym

A multicenter prospective study for the utility of a target sample check illuminator

Scientific Title

A multicenter prospective study for the utility of a target sample check illuminator (TSCI), concerning the detection of target specimens in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) samples for pancreatic masses and lymph node tumors.

Scientific Title:Acronym

A multicenter prospective study for the utility of a target sample check illuminator

Region

Japan


Condition

Condition

pancreatic masses and lymph node tumors.

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will examine the advantage of introducing the use of a TSCI with EUS-FNA for pancreatic masses and lymph node tumors without using ROSE.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The detection rate for target specimens by viewing only.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

We will perform endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for pancreatic masses and lymph node tumors.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Age of patients at start of the trial is 20 years or older
2) Patients with digestive malignant tumors with the need of pathological diagnosis before treatment

Key exclusion criteria

1) People who have taken chemotheraphy for malignant tumors within one month before the start of the trial.
2) Patients who have had other cancers
3) Patients who are taking anticoagulant or antithrombotic drugs
4) Women who are pregnant or are possibly pregnan

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Kazuya
Middle name
Last name Matsumoto

Organization

Tottori University School of medicine

Division name

Division of Medicine and Clinical Science

Zip code

6838504

Address

36-1 Nishi-cho, Yonago 683-8504, Japan

TEL

0859-38-6527

Email

ayano0620@hotmail.co.jp


Public contact

Name of contact person

1st name Kazuya
Middle name
Last name Matsumoto

Organization

Tottori University School of medicine

Division name

Division of Medicine and Clinical Science

Zip code

6838504

Address

36-1 Nishi-cho, Yonago 683-8504, Japan

TEL

0859-38-6527

Homepage URL


Email

ayano0620@hotmail.co.jp


Sponsor or person

Institute

Tottori University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tottori University Hospital

Address

36-1 Nishi-cho, Yonago 683-8504, Japan

Tel

0859-38-6527

Email

ayano0620@hotmail.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 27 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

56

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 22 Day

Date of IRB

2016 Year 06 Month 22 Day

Anticipated trial start date

2016 Year 07 Month 27 Day

Last follow-up date

2022 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 27 Day

Last modified on

2022 Year 08 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026905


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name